Strepsils sugar-free lemon-flavored lollipops No. 16

Instructions for Strepsils sugar-free lemon-flavored lozenges No. 16

Composition

active ingredients: 2,4-dichlorobenzyl alcohol, amylmetacresol;

1 lollipop contains: 2,4-dichlorobenzyl alcohol 1.2 mg; amylmetacresol 0.6 mg;

excipients: lemon flavoring, tartaric acid, sodium saccharin, liquid maltitol, isomalt.

Dosage form

Lollipops.

Main physicochemical properties: round white to pale yellow lollipops with an "S" sign on both sides.

Pharmacotherapeutic group

Drugs used in throat diseases. Antiseptics. Dichlorobenzyl alcohol. ATX code R02A A03.

Pharmacological properties

Pharmacodynamics

The drug has antiseptic properties. Active against a wide range of gram-positive and gram-negative microorganisms in vitro; has an antifungal effect. The effectiveness of the drug is due to the presence of two broad-spectrum antibacterial components that relieve sore throat and reduce inflammation. Amylmetacresol destroys the structure of bacterial proteins, which is manifested by a bactericidal effect. 2,4-dichlorobenzyl alcohol has a bacteriostatic effect due to dehydration of the bacterial cell.

Due to the low absorption of the drug into the blood, Strepsils® is a topical agent. Given this, pharmacokinetic parameters have not been determined.

Indication

As an antiseptic to relieve sore throats.

Contraindication

Hypersensitivity to any component of the drug.

Interaction with other medicinal products and other types of interactions

Interaction studies have not been conducted.

Application features

The indicated maximum dose should not be exceeded.

If symptoms persist for 3 days or worsen, are accompanied by high fever, headache, and other symptoms, you should consult a doctor for additional adjustment of the treatment regimen.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

Isomalt and liquid maltitol, which are part of the drug, can cause a mild laxative effect (after using several lozenges per day).

Not recommended for use in patients with hereditary fructose intolerance, glucose-galactose malabsorption and sucrose-isomaltase insufficiency.

Ability to influence reaction speed when driving vehicles or other mechanisms

Studies on the effect on the ability to drive or operate other mechanisms have not been conducted.

Use during pregnancy or breastfeeding

Pregnancy: There are no or limited amount of data from the use of amylmetacresol and 2,4-dichlorobenzyl alcohol. As with all medicines, caution should be exercised when using this medicine during pregnancy. If necessary, seek medical advice.

Breastfeeding: It is not known whether amylmetacresol, 2,4-dichlorobenzyl alcohol or metabolites are excreted in human milk. A risk to the breastfed newborn or infant cannot be excluded.

There are no data on the effect on fertility.

Method of administration and doses

For oral use.

Use the lowest dose for the shortest time needed to relieve symptoms.

Adults and children over 6 years of age are recommended to suck 1 lollipop every 2–3 hours. The lollipop should be sucked slowly until completely dissolved. Do not use more than 8 lollipops per day. The maximum recommended duration of use is 3 days. No dose adjustment is required for elderly patients.

Children

Given the dosage form, the drug is contraindicated for use in children under 6 years of age.

Overdose

Accidental or intentional overdose of the drug may manifest only as symptoms of discomfort from the gastrointestinal tract. In this case, you should stop using the drug and consult a doctor. Treatment is symptomatic.

Adverse reactions

The following adverse reactions have been observed with short-term use of 2,4-dichlorobenzyl alcohol and amylmetacresol at non-prescription doses. Other adverse reactions may occur with chronic disease treatment and long-term use.

Adverse reactions are classified by system organ class and frequency. The frequency is defined as follows: very common: ≥ 1/10; common: ≥ 1/100 and < 1/10; uncommon: ≥ 1/1,000 and < 1/100; rare: ≥ 1/10,000 and < 1/1,000; very rare: < 1/10,000 and frequency not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.

On the part of the immune system

Frequency unknown: hypersensitivity reactions, which may include rash, angioedema, urticaria, bronchospasm and hypotension with loss of consciousness.

From the respiratory tract and mediastinal organs.

Frequency unknown: pharyngeal edema (swelling of the throat).

Frequency not known: Oral discomfort, which may include throat irritation, oral paraesthesia (tingling sensation in the mouth), oral swelling and glossodynia (tongue pain).

Frequency unknown: dyspepsia, nausea, stomatitis, abdominal pain.

On the skin and subcutaneous tissue.

Frequency unknown: skin rash, itching, erythema.

Expiration date

3 years.

Storage conditions

Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.

Packaging

8 lollipops in a blister, 2 blisters in a cardboard box.

Vacation category

Without a prescription.

Producer

Reckitt Benckiser Healthcare International Limited.

Location of the manufacturer and its business address

Nottingham site, Thane Road, Nottingham, NG90 2DB, United Kingdom.